← Back to Search

LDCT Lung Screening for Early Detection of Lung Cancer

N/A

Recruiting

Led By Daniel Carrizosa, MD

Research Sponsored by Daniel Carrizosa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 40-54 years at the time of consent.

Ability to read and understand the English and/or Spanish language.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 months

Awards & highlights

Study Summary

This trial is testing whether lowering the minimum age for low-dose CT screening from 55 to 50 will decrease mortality in a high-risk population.

Who is the study for?

This trial is for people aged 40-54 who have a significant smoking history (at least 30 pack years), are currently smoking or quit within the last 15 years, and can understand English/Spanish. They must consent to share health information and follow study procedures. Those with past lung cancer diagnosis, CT scan contraindications, or pregnancy cannot join.Check my eligibility

What is being tested?

The study tests if lowering the age for Low-dose Computed Tomography (LDCT) screening can help detect lung cancer earlier in smokers or recent quitters aged 40-54. This follows evidence that LDCT improves survival rates in older individuals.See study design

What are the potential side effects?

While LDCT itself has minimal side effects, potential risks include exposure to low levels of radiation which may slightly increase the risk of developing cancer over one's lifetime.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 54 years old.

Select...

I can read and understand either English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Lung cancer diagnosis rate in individuals 40-54 years of age at their first screening (T0) with mobile low-dose CT.

Secondary outcome measures

Impact of baseline demographic (including insurance status), socioeconomic, and healthcare-related factors on lung cancer rates and positive screening rates

Incidence rate of all types of cancer found with low-dose lung CT during lung cancer screening

Lung cancer diagnosis rate in individuals 40-54 years of age at subsequent screening visits (T1 and T2)

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Single ArmExperimental Treatment1 Intervention

Mobile Low-dose Computed Tomography (LDCT) Screening

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Daniel CarrizosaLead Sponsor

Leon Levine FoundationUNKNOWN

Wake Forest University Health SciencesLead Sponsor

1,241 Previous Clinical Trials

1,003,077 Total Patients Enrolled

Media Library

Mobile Low-dose Computed Tomography (LDCT) Screening Clinical Trial Eligibility Overview. Trial Name: NCT04577599 — N/A

Lung Cancer Research Study Groups: Single Arm

Lung Cancer Clinical Trial 2023: Mobile Low-dose Computed Tomography (LDCT) Screening Highlights & Side Effects. Trial Name: NCT04577599 — N/A

Mobile Low-dose Computed Tomography (LDCT) Screening 2023 Treatment Timeline for Medical Study. Trial Name: NCT04577599 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the eligibility criteria for participating in this trial?

"In order to be accepted into this research study, individuals must have lung cancer and their age falls between 40 and 54. Altogether 1160 participants will be enlisted in the project."

Answered by AI

Can senior citizens aged 70 years and above be considered for participation in this research?

"To be eligible for this study, applicants must range in age from 40 to 54 years old. There are 44 studies catering to patients younger than 18 and 1624 trials available for those over 65."

Answered by AI

Are there currently any openings in this clinical trial for participants?

"Affirmative. As per the information posted on clinicaltrials.gov, this research venture is currently seeking participants after being initially published on 6 January 2021 and most recently modified on 10 September 2022. 1160 individuals are expected to enrol from a single site of recruitment."

Answered by AI

What is the recruitment size for this research endeavor?

"Affirmative. Clinicaltrials.gov's records show that this trial, which was launched on June 1st 2021 and last modified on September 10th 2022 is still recruiting participants - 1160 to be exact from a single medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54

Daniel Carrizosa 2021. "Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04577599.

All > Metastatic Lung Cancer > Lung Cancer